Seer (SEER) Projected to Post Earnings on Thursday

Seer (NASDAQ:SEER) is anticipated to announce its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $4.60 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 4:30 PM ET.

Seer Stock Up 4.0%

Seer stock opened at $2.06 on Tuesday. The firm has a fifty day moving average of $1.88 and a 200-day moving average of $2.02. Seer has a 52-week low of $1.62 and a 52-week high of $2.41. The firm has a market capitalization of $114.93 million, a P/E ratio of -1.51 and a beta of 1.63.

Hedge Funds Weigh In On Seer

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its position in shares of Seer by 2.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 235,485 shares of the company’s stock worth $431,000 after acquiring an additional 6,304 shares during the last quarter. Shay Capital LLC grew its stake in Seer by 17.7% during the 3rd quarter. Shay Capital LLC now owns 73,571 shares of the company’s stock valued at $160,000 after purchasing an additional 11,073 shares in the last quarter. Occudo Quantitative Strategies LP purchased a new stake in Seer during the 2nd quarter worth approximately $25,000. Vanguard Group Inc. raised its position in shares of Seer by 0.9% in the 3rd quarter. Vanguard Group Inc. now owns 2,221,404 shares of the company’s stock valued at $4,820,000 after purchasing an additional 18,760 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its stake in shares of Seer by 46.3% during the 2nd quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock valued at $135,000 after buying an additional 20,000 shares during the last quarter. 75.20% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a research report on Thursday, January 22nd. Wall Street Zen upgraded Seer to a “hold” rating in a research note on Saturday, December 13th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.